[1]
S. Onsanit, K. Wanichang, and K. Anutarapongpan, “Cost-Effectiveness of Crystalline and Amorphous Atorvastatin in the Secondary Prevention of Cardiovascular Disease”, SRIMEDJ, vol. 34, no. 3, pp. 219–225, May 2019.